Mood Disorder Clinical Trial
Official title:
The Role of Emotion in the Development of Psychopathology
The dysregulated experience and expression of emotion is implicated in psychiatric disorders associated both with externalizing problems (aggressive, antisocial behaviors) and internalizing problems (anxiety, depression). Adolescence is a critical juncture in the development of these disorders because of the increased incidence and differentiation of clinical problems during this time period. This is a biobehavioral, longitudinal investigation of the role of emotion in the development of psychopathology in adolescence. The focus is on socialization experiences and biological processes that contribute to emotion dysregulation and disorder in male and female youths between 11 and 16 years of age. Groups studied include (1) comorbid externalizers and internalizers, (2) externalizers only, (3) internalizers only, and (4) asymptomatic youth. The adolescents are assessed again two years later, with instruments and paradigms similar to those used at Time 1. One theme pertains to the integration and disconnection of emotions across systems (e.g., physiological and self-report of experience), and how different patterns of emotion relate to psychopathology. A second theme pertains to development changes in how disorders are manifested (e.g., increased differentiation along gender specific pathways). The anticipated number of patient days per year is 240 for adolescents and mothers, and 120 days for fathers.
Status | Completed |
Enrollment | 1200 |
Est. completion date | May 2003 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A and older |
Eligibility |
INCLUSION CRITERIA Subjects and their families will be recruited from the community. Inclusionary criteria will be based on mother and youth report of (a) emotion regulation problems and (b) the presence of subclinical or clinical symptomatology based on broad-band scales of the Youth Self-Report or mother's report of behavior problems. Individuals meeting entry criteria will be offered entry into the study, and others will be notified. EXCLUSION CRITERIA A debilitating physical impairment (e.g., seizure disorder, cerebral palsy, head trauma). Significant intellectual impairment (i.e., IQ less than 70). History of psychosis. Any condition that would impair a participant's ability to respond to the study's paradigms will be excluded from this study at the time of screening. |
N/A
Country | Name | City | State |
---|---|---|---|
United States | National Institute of Mental Health (NIMH) | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Mental Health (NIMH) |
United States,
Akil H, Haskett RF, Young EA, Grunhaus L, Kotun J, Weinberg V, Greden J, Watson SJ. Multiple HPA profiles in endogenous depression: effect of age and sex on cortisol and beta-endorphin. Biol Psychiatry. 1993 Jan 15;33(2):73-85. — View Citation
Anderson JC, Williams S, McGee R, Silva PA. DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry. 1987 Jan;44(1):69-76. — View Citation
Angold A, Costello EJ. Depressive comorbidity in children and adolescents: empirical, theoretical, and methodological issues. Am J Psychiatry. 1993 Dec;150(12):1779-91. Review. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00001919 -
Neuroimaging of St. John's Wort-Induced Changes of Serotonin Metabolism in Normal Subjects
|
N/A | |
Completed |
NCT00026832 -
Examination of Brain Serotonin Receptors in Patients With Mood Disorders
|
||
Completed |
NCT01951508 -
Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study
|
Phase 0 | |
Terminated |
NCT01830088 -
Family Based Treatment of Depressed Adolescents (AHUS)
|
N/A | |
Completed |
NCT01269710 -
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
|
N/A | |
Completed |
NCT00001146 -
Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial
|
Phase 2 | |
Completed |
NCT00001170 -
Study of the Psychological Development of Children of Parents With and Without Affective Disorders
|
N/A | |
Completed |
NCT00001192 -
Neuropsychological Evaluation of Psychiatric and Neurological Patients
|
N/A | |
Completed |
NCT02189057 -
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression
|
N/A | |
Completed |
NCT01473550 -
Mental Health Engagement Network (MHEN)
|
N/A | |
Completed |
NCT00990067 -
Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)
|
Phase 1 | |
Completed |
NCT00794040 -
A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
|
Phase 2 | |
Completed |
NCT02819986 -
Effectiveness of Using the Progressive Goal Attainment Program in Anxiety and Mood Disorders
|
N/A | |
Completed |
NCT03538860 -
Validation of an Automated Online Language Interpreting Tool - Phase Two.
|
N/A | |
Completed |
NCT00016731 -
Adolescence, Puberty, and Emotion Regulation
|
||
Completed |
NCT02721316 -
Outpatient Nurse Monitoring Under the Prevention of Recurrent Suicidal
|
N/A | |
Recruiting |
NCT02443636 -
The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Registry
|
||
Terminated |
NCT01493323 -
Functional Imaging of Psychic Pain
|
N/A | |
Completed |
NCT00699218 -
A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Bipolar Depression
|
N/A | |
Completed |
NCT00001545 -
Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders
|
Phase 2 |